05.11.2012 Views

Monthly M&A Insider - Mergermarket

Monthly M&A Insider - Mergermarket

Monthly M&A Insider - Mergermarket

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Introduction<br />

Despite a reasonably subdued first quarter of M&A, there have still been some deals which have<br />

defied the trend, such as the Pfizer/Wyeth deal, worth a cool $64bn.<br />

In North America in Q1 there were 539 deals worth a total<br />

of $226.3bn. The highest deal for the month of March in<br />

the region was Merck & Co’s acquisition of Schering Plough<br />

Corporation for $43.1bn, which has taken on a similar form of<br />

the reverse termination fee that was used in the Pfizer deal,<br />

demonstrating the watertight measures needed to complete<br />

a deal in the current climate.<br />

In Europe, the first quarter of 2009 saw a total of €82.7bn<br />

from 675 deals. Of the top 15 deals, three were government<br />

bailouts. These included the much publicised bailout of Lloyd<br />

banking group and the Royal Bank of Scotland. Additionally,<br />

the Government of the Flemish region in Belgium acquired<br />

KBC Group, for €2bn. The Energy, Mining & Utilities sector<br />

featured heavily on the top deals table, with eight of the top<br />

15 deals originating in the sector. Endesa’s takeover by Enel<br />

came in with the highest value at €11.1bn.<br />

Head of Research – Elias Latsis<br />

Editor – Anna Henderson<br />

Europe: Sola Akinola<br />

Asia-Pacific: Debbie Jung, Chunshek Chan<br />

Greater China: Maggie Cheung, Debbie Jung/Maggie Cheung<br />

Japan: Shunsuke Okano<br />

Australia: Cicilie Lofsgard<br />

North America: Yasmin Salfati, Irina Arefyeva<br />

Russia: Aksana Fitzpatrick<br />

France: Damien Julliard, Sylvia Traganida<br />

CEE/CIS: Nulifer Sezer, Magdalena Urbanska<br />

Moving onto April there are certainly some positive<br />

developments in M&A, and although this is not yet reason to<br />

celebrate, it is encouraging that the frequency and value of<br />

deals may be starting to pick up slightly. Sun Microsystems<br />

is to be bought by US software services company, Oracle for<br />

$6.7bn, whilst in the pharmaceutical sphere GlaxoSmithKline<br />

has agreed to acquire Stiefel for $2.9bn. Whether this activity<br />

continues is tentative, and a representative from Nomura<br />

recently supported this view when he told the Financial<br />

Times that, “confidence is still fragile and much will depend<br />

on how markets behave over the coming months.”<br />

mergermarket are pleased to offer you the April edition of<br />

<strong>Monthly</strong> M&A <strong>Insider</strong>, a publication which provides you with<br />

features by mergermarket journalists, and all monthly deals,<br />

potential activity and deal drivers. We hope you continue to<br />

find it useful.<br />

By Anna Henderson, Remark<br />

Benelux: Kathleen Van Aerden<br />

UK: Virginia Christopanou, Petra Witowski<br />

Nordic: Laya Montelibano<br />

Germany: Sola Akinola<br />

Italy: Giovanni Gallorini, Zaynab Dost<br />

Iberia: Samuel Tedjasukmana, Virginia Garcia Martinez<br />

LatAm: Jennifer Ruiz<br />

For advertising opportunities contact:<br />

Simon Anam<br />

Tel: +44 (0)20 7059 6124<br />

sa@mergermarket.com<br />

<strong>Monthly</strong> M&A Report – 3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!